{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:32:11Z","timestamp":1747153931778,"version":"3.40.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13139-020-00676-1","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T06:04:15Z","timestamp":1609999455000},"page":"27-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Influence of H2-Receptor Antagonist Administration to the 24-h Uptake of I-131 in the Thyroid Gland"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-3190","authenticated-orcid":false,"given":"Andreas","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendra","family":"Budiawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Hussein S.","family":"Kartamihardja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"676_CR1","first-page":"34","volume":"27","author":"Task Force on Thyroid Disease TIS of E","year":"2014","unstructured":"Task Force on Thyroid Disease TIS of E. Indonesian clinical practice guidelines for hyperthyroidism. J ASEAN Fed Endocr Soc. 2014;27:34.","journal-title":"J ASEAN Fed Endocr Soc"},{"key":"676_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"676_CR3","volume-title":"Essentials of nuclear medicine","author":"FA Mettler","year":"2012","unstructured":"Mettler FA. Essentials of nuclear medicine. 6th ed. Philadelphia: Elsevier Saunders; 2012.","edition":"6"},{"key":"676_CR4","first-page":"1188","volume":"43","author":"JK Chung","year":"2002","unstructured":"Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med. 2002;43:1188\u2013200.","journal-title":"J Nucl Med"},{"key":"676_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/108497803322285206","volume":"18","author":"L Johansson","year":"2003","unstructured":"Johansson L, Leide-Syegborn S, Mattsson S, Nosslin B. Biokinetics of iodine in man: refinement of current ICRP dosimetry models. Cancer Biother Radiopharm. 2003;18:445\u201350.","journal-title":"Cancer Biother Radiopharm"},{"key":"676_CR6","first-page":"397","volume":"28","author":"RR Grayson","year":"1960","unstructured":"Grayson RR. Factors which influence the radioactive iodine thyroidal uptake test. Am J. 1960;28:397\u2013415.","journal-title":"Am J"},{"key":"676_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/978-3-319-26236-9_11","volume-title":"Nuclear oncology: from pathophysiology to clinical applications","author":"R Elisei","year":"2017","unstructured":"Elisei R, Agate L, Mazzarri S, Bottici V, Guidoccio F, Molinaro E, et al. Diagnostic application of nuclear medicine: thyroid tumors. In: Strauss HW, Mariani G, Volterrani D, Larson SM, editors. Nuclear oncology: from pathophysiology to clinical applications. 2nd ed. Switzerland: Springer International; 2017. p. 545\u201383.","edition":"2"},{"key":"676_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5056\/jnm.2011.17.3.287","volume":"17","author":"N Takashi","year":"2011","unstructured":"Takashi N, Takaomi K, Yuji O, Kento I, Shogo Y, Tadahiko S, et al. Effects of histamine-2 receptor antagonist and proton pump inhibitors on the rate of gastric emptying: a crossover study using a continuous real-time 13C breath test (BreathID system). J Neurogastroenterol Motil. 2011;17:287\u201393.","journal-title":"J Neurogastroenterol Motil"},{"key":"676_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2967\/jnmt.115.160697","volume":"43","author":"O Edwards","year":"2015","unstructured":"Edwards O, Yakish ED, CNMT, Wang L-M, Wu Q, Hoffman JM, et al. Histamine receptor 1 and 2 antagonist alter biodistribution of radioiodine. J Nucl Med Technol. 2015;43:214\u20139.","journal-title":"J Nucl Med Technol"},{"key":"676_CR10","first-page":"1266","volume":"37","author":"D Becker","year":"1996","unstructured":"Becker D, Charkes ND, Dworkin H, Hurley J, McDougall IR, Price D, et al. Procedure guideline for thyroid uptake measurement: 1.0. J Nucl Med. 1996;37:1266\u20138.","journal-title":"J Nucl Med"},{"key":"676_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1631\/jzus.B1400131","volume":"15","author":"C-H Yeong","year":"2014","unstructured":"Yeong C-H, Cheng M-H, Ng K-H. Therapeutic radionuclides in nuclear medicine: current and future prospects. J Zhejiang Univ Sci B. 2014;15:845\u201363.","journal-title":"J Zhejiang Univ Sci B"},{"key":"676_CR12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJM195506022522204","volume":"252","author":"JH Means","year":"1955","unstructured":"Means JH. Historical background of the use of radioactive iodine in medicine. N Engl J Med. 1955;252:936\u201340.","journal-title":"N Engl J Med"},{"key":"676_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2967\/jnumed.112.105148","volume":"53","author":"EB Silberstein","year":"2012","unstructured":"Silberstein EB, Alavi A, Balon HR, Clarke SEM, Divgi C, Gelfand MJ, et al. The SNM practice guideline for therapy of thyroid disease with 131I 3.0*. J Nucl Med. 2012;53:1\u201319.","journal-title":"J Nucl Med"},{"key":"676_CR14","first-page":"3705","volume":"28","author":"A Sezer","year":"2017","unstructured":"Sezer A, Celik M, Usta U, Altun GD. Gastric damage related to radioactive iodine treatment and protective effect of amifostine. Biomed Res. 2017;28:3705\u201310.","journal-title":"Biomed Res"},{"key":"676_CR15","first-page":"498","volume":"22","author":"R Corinaldesi","year":"1984","unstructured":"Corinaldesi R, Scarpignato C, Galassi A, Stanghellini V, Calamelli R, Bertaccini G, et al. Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man. Int J Clin Pharmacol Ther Toxicol. 1984;22:498\u2013501.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"676_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/003693307602100107","volume":"21","author":"JA Forrest","year":"1976","unstructured":"Forrest JA, Heading RC, Park J, Carter DC, Lennon J, Lidgard G, et al. Effect of histamine H2-receptor blockade on gastric emptying and serum gastrin in man. Scott Med J. 1976;21:23\u20137.","journal-title":"Scott Med J"},{"key":"676_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/BF01965134","volume":"12","author":"G Bertaccini","year":"1982","unstructured":"Bertaccini G, Coruzzi G. Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine. Agents Actions. 1982;12:168\u201371.","journal-title":"Agents Actions"}],"container-title":["Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-020-00676-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13139-020-00676-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13139-020-00676-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T11:12:14Z","timestamp":1613128334000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13139-020-00676-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1007\/s13139-020-00676-1","relation":{},"ISSN":["1869-3474","1869-3482"],"issn-type":[{"type":"print","value":"1869-3474"},{"type":"electronic","value":"1869-3482"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Andreas Lim, Hendra Budiawan and Achmad Hussein Sundawa Kartamihardja declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of Dr. Hasan Sadikin General Hospital Bandung and had been approved by the Ethical Committee (Number: LB.02.01\/X.6.5\/195\/2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}